David S. Ziegler, MD, PhD

Sydney Children's Hospital, Randwick NSW and School of Women's and Children's Health, University of New South Wales Sydney
Sydney, New South Wales, Australia

Presentation(s):

• Paper 01 - LAROTRECTINIB (LARO) SAFETY AND EFFICACY IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS AND PROLONGED RESPONSE

  Thursday, November 13, 2025
  10:30 AM - 11:30 AM EST

  Disclosure information not submitted.